Skip to main content
. 2000 Mar;74(6):2888–2894. doi: 10.1128/jvi.74.6.2888-2894.2000

FIG. 3.

FIG. 3

In vivo tumor elimination assay. Groups of 10 mice were injected subcutaneously with 5 × 104 TC-1 or B16F1 tumor cells and, after 1 week, were immunized with 5 × 1010 viral particles of rAAV E7CTL-hsp or rAAV lacZ or phosphate-buffered saline (PBS) (mock). The tumor volume was monitored once a week. The data are represented as means and standard errors of each group.

HHS Vulnerability Disclosure